Statin use and musculoskeletal pain among adults with and without arthritis

American Journal of Medicine

Volumn 125, Issue 2, 2012, Pages 176-182

  Buettner, Catherine ^a,b   Rippberger, Matthew J ^b   Smith, Julie K ^b   Leveille, Suzanne G ^a,b,c   Davis, Roger B ^a,b,d   Mittleman, Murray A ^a,b,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS BOSTON   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Arthritis; Hydroxymethylglutaryl CoA reductase inhibitors; Musculoskeletal diseases; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTHRITIS; ARTICLE; CONFIDENCE INTERVAL; FEMALE; HEALTH SURVEY; HUMAN; LEG PAIN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; MUSCULOSKELETAL PAIN; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; PREVALENCE; PRIORITY JOURNAL; SELF REPORT;

AGED; ARTHRITIS; CARDIOVASCULAR DISEASES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUSCULOSKELETAL PAIN; NEOPLASMS; NUTRITION SURVEYS; PREVALENCE; UNITED STATES;

EID: 84862907917     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.08.007     Document Type: Article

References (24)

1. C.P. Cannon, B.A. Steinberg, S.A. Murphy, J.L. Mega, E. Braunwald Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy J Am Coll Cardiol 48 2006 438
2. B.M.Y. Cheung, I.J. Lauder, C.P. Lau, C.R. Kumana Meta analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes Br J Clin Pharmacol 57 2004 640 651 (Pubitemid 38582185)
3. G.C. Fonarow, K.E. Watson Effective strategies for long-term statin use Am J Cardiol 92 2003 27 34
4. K. Maggon Best-selling human medicines 2002-2004 Drug Discov Today 10 2005 739 742 (Pubitemid 40744913)
5. D. Mann, K. Reynolds, D. Smith, P. Muntner Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program Guidelines (September) Ann Pharmacother 42 2008 1208 1215 Epub 2008 Jul 22
6. J.M. McKenney, M.H. Davidson, T.A. Jacobson, J.R. Guyton Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force Am J Cardiol 97 8A 2006 89C 94C
7. P.D. Thompson, P. Clarkson, R.H. Karas Statin-associated myopathy JAMA 289 2003 1681 1690 (Pubitemid 37430274)
8. C. Buettner, R.B. Davis, S.G. Leveille, M.A. Mittleman, K.J. Mukamal Prevalence of musculoskeletal pain and statin use J Gen Intern Med 23 2008 1182 1186
9. National Health and Nutrition Examination Survey Centers for Disease Control and Prevention http://www.cdc.gov/nchs/nhanes/about-nhanes.htm Accessed February 2, 2011
10. National Health and Nutrition Examination Survey, NCHS Research Ethics Review Board (ERB) Approval http://www.cdc.gov/nchs/nhanes/irba98.htm Accessed February 2, 2011
11. G.S. Bieler, G.G. Brown, R.L. Williams, D.J. Brogan Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data Am J Epidemiol 171 2010 618 623
12. E. Bruckert, G. Hayem, S. Dejager, C. Yau, B. Begaud Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients the PRIMO study Cardiovasc Drugs Ther 19 2005 403 414 (Pubitemid 43228152)
13. S. Franc, S. Dejager, E. Bruckert, M. Chauvenet, P. Giral, G. Turpin A comprehensive description of muscle symptoms associated with lipid-lowering drugs Cardiovasc Drugs Ther 17 2003 459 465 (Pubitemid 38339916)
14. K.E. Hansen, J.P. Hildebrand, E.E. Ferguson, J.H. Stein Outcomes in 45 patients with statin-associated myopathy Arch Intern Med 165 2005 2671 2676 (Pubitemid 41785067)
15. D.A. Frieze Musculoskeletal pain associated with corticosteroid therapy in cancer Curr Pain Headache Rep 14 2010 256 260
16. R.W. Kuncl, G. Duncan, D. Watson, K. Alderson, M.A. Rogawski, M. Peper Colchicine myopathy and neuropathy N Engl J Med 316 1987 1562 1568 (Pubitemid 17083593)
17. A. Kashani, C.O. Phillips, J.M. Foody Risks associated with statin therapy: a systematic overview of randomized clinical trials Circulation 114 2006 2788 2797 (Pubitemid 46018281)
18. M. Silva, M.L. Matthews, C. Jarvis Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy Clin Ther 29 2007 253 260 (Pubitemid 46661859)
19. M.A. Silva, A.C. Swanson, P.J. Gandhi, G.R. Tataronis Statin-related adverse events: a meta-analysis Clin Ther 28 2006 26 35 (Pubitemid 43254987)
20. M. Ladouceur, E. Rahme, C.A. Pineau, L. Joseph Robustness of prevalence estimates derived from misclassified data from administrative databases Biometrics 63 2007 272 279
21. E. Losina, J. Barrett, J.A. Baron, J.N. Katz Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients J Clin Epidemiol 56 2003 515 519 (Pubitemid 36842908)
22. J.J. Sacks, L.R. Harrold, C.G. Helmick, J.H. Gurwitz, S. Emani, R.A. Yood Validation of a surveillance case definition for arthritis J Rheumatol 32 2005 340 347 (Pubitemid 40209135)
23. FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury Postmarket Drug Safety Information for Patients and Providers http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm204882.htm Accessed February 2, 2011
24. FDA Public Health Advisory for Crestor (rosuvastatin) Postmarket Drug Safety Information for Patients and Providers http://www.fda.gov/Drugs/ DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/PublicHealthAdvisories/ucm051756. htm Accessed February 2, 2011